Market Tracker

05/30 4:45pm ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

0.4169
Delayed Data
As of May 27
 +0.0069 / +1.68%
Today’s Change
0.35
Today|||52-Week Range
5.19
-75.76%
Year-to-Date
No recent news for Orexigen Therapeutics Inc.

Today’s Trading

Previous close0.41
Today’s open0.43
Day’s range0.39 - 0.43
Volume1,377,194
Average volume (3 months)2,170,198
Market cap$62.0M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-62.50%
Earnings growth (this year)-6.25%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-55.95%
P/E ratioNM
Price/Sales9.22
Price/Book1.86

Competitors

 Today’s
change
Today’s
% change
RNNRexahn Pharmaceutica...+0.00+1.18%
AVIRAviragen Therapeutic...-0.14-8.81%
MSTXMast Therapeutics In...-0.00-1.15%
KURAKura Oncology Inc+0.15+5.12%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$24.5M
Annual profit (last year)-$68.7M
Net profit margin-280.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Inside Director
Michael A. Narachi
Chief Commercial Officer &
Executive VP
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts